Preserve common limb in duodenal-jejunal bypass surgery benefits rats with type 2-like diabetes

Obesity Surgery

Volumn 24, Issue 3, 2014, Pages 405-411

  Zhang, Shi Yun ^a   Sun, Xue Jun ^a   Zheng, Jian Bao ^a   Wang, Wei ^a   Liu, Dong ^a   Chen, Nan Zheng ^a   He, Sai ^a   Huo, Xiong Wei ^a   Smith, Wanli ^b  

^a XI'AN JIAOTONG UNIVERSITY   (China)

^b UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

Author keywords

Duodenal jejunal bypass; Energy intake; Glucagon like peptide 1; Goto Kakizaki (GK) rat; Type 2 diabetes

Indexed keywords

CHOLESTEROL; GLUCOSE; INSULIN; PEPTIDE; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CALORIC INTAKE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET RESTRICTION; DUODENAL JEJUNAL BYPASS; DUODENUM; ENERGY; ENERGY BALANCE; FECES ANALYSIS; FOOD INTAKE; GASTROINTESTINAL SURGERY; GLUCOSE TOLERANCE; GLYCEMIC CONTROL; GOTO KAKIZAKI RAT; INSULIN SENSITIVITY; INTESTINE SURGERY; JEJUNUM; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; ORGAN PRESERVATION; PRIORITY JOURNAL; RAT; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT GAIN;

ANIMALS; BARIATRIC SURGERY; BLOOD GLUCOSE; BODY WEIGHT; DIABETES MELLITUS, EXPERIMENTAL; DUODENUM; GLUCAGON-LIKE PEPTIDE 1; GLUCOSE; GLUCOSE TOLERANCE TEST; INSULIN RESISTANCE; JEJUNUM; MALE; RATS;

EID: 84898036072     PISSN: 09608923     EISSN: 17080428     Source Type: Journal    
DOI: 10.1007/s11695-013-1103-z     Document Type: Article

References (37)

1. Chan JC, Malik V, Jia W, et al. Diabetes in Asia: epidemiology, risk factor, and pathophysiology. JAMA. 2009;301(20):2129-240. doi: 10.1001/jama.2009.726.
2. Olokoba AB, Obateru OA, Olokoba LB. Type 2 diabetes mellitus: a review of current trends. Oman Med J. 2012;27(4):269-73. doi:10. 5001/omj.2012.68.
3. Lee KW. Costs of diabetes mellitus in Korea. Diabetes Metab J. 2011;35(6):567-70. doi:10.4093/dmj.2011.35.6.567.
4. Barceló A, Aedo C, Rajpathak S. The cost of diabetes in Latin America and the Caribbean. Bull World Health Organ. 2003;81(1):19-27. (Pubitemid 36168649)
5. Pories WJ, Swanson MS, MacDonald KG, et al. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg. 1995;222(3):339-50.
6. Salehi M, Prigeon RL, D'Alessio DA. Gastric bypass surgery enhances glucagon-like peptide 1-stimulated postprandial insulin secretion in humans. Diabetes. 2011;60(9):2308-14. doi:10.2337/db11-0203.
7. Ramos AC, Galvão Neto MP, de Souza YM, et al. Laparoscopic duodenal-jejunal exclusion in the treatment of type 2 diabetes mellitus in patients with BMI <30 kg/m2 (LBMI). Obes Surg. 2009;19(3):307-12. doi:10.1007/s11695-008-9759-5.
8. Scopinaro N, Adami GF, Marinari GM, et al. Biliopancreatic diversion. World J Surg. 1998;22(9):936-46. (Pubitemid 28374611)
9. Guidone C, Manco M, Valera-Mora E, et al. Mechanisms of recovery from type 2 diabetes after malabsorptive bariatric surgery. Diabetes. 2006;55(7):2025-31. (Pubitemid 44509976)
10. Rubino F, Gagner M. Potential of surgery for curing type 2 diabetes mellitus. Ann Surg. 2002;236(5):554-9. (Pubitemid 35246885)
11. Jørgensen NB, Jacobsen SH, Dirksen C, et al. Acute and long-term effects of Roux-en-Y gastric bypass on glucose metabolism in subjects with type 2 diabetes and normal glucose tolerance. Am J Physiol Endocrinol Metab. 2012;303(1):E122-31. doi:10.1152/ ajpendo.00073.2012.
12. Gumbs AA, Modlin IM, Ballantyne GH. Changes in insulin resistance following bariatric surgery: role of caloric restriction and weight loss. Obes Surg. 2005 Apr;15(4):462-73. (Pubitemid 40605067)
13. Scott WR, Batterham RL. Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy: understanding weight loss and improvements in type 2 diabetes after bariatric surgery. Am J Physiol Regul Inter Comp Physiol. 2011;301(1):R15-27. doi:10. 1152/ajpregu.00038.2011.
14. Sundbom M, Gustavsson S. Bariatric surgery. Clin Dermatol. 2004;22(4):325-31. (Pubitemid 39314619)
15. Wang TT, Hu SY, Gao HD. Ileal transposition controls diabetes as well asmodified duodenal jejunal bypasswith better lipid lowering in a nonobese rat model of type II diabetes by increasing GLP-1. Ann Surg. 2008;247(6):968-75. doi:10.1097/SLA.0b013e318172504d. (Pubitemid 351770417)
16. Galli J, Li LS,GlaserA, et al.Genetic analysis of non-insulin dependent diabetes mellitus in the GK rat. Nat Genet. 1996;12(1):31-7. (Pubitemid 26011316)
17. Rubino F, Marescaux J. Effect of duodenal-jejunal exclusion in a non-obese animal model of type 2 diabetes. A new perspective for an old disease. Ann Surg. 2004;239(1):1-11. (Pubitemid 38176365)
18. Rubino F, Forgione A, Cummings DE, et al. The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes. Ann Surg. 2006;244(5):741-9. (Pubitemid 44629948)
19. VÅge V, GÅsdal R, Laukeland C, et al. The biliopancreatic diversion with a duodenal switch (BPDDS): how is it optimally performed? Obes Surg. 2011;21(12):1864-9. doi:10.1007/s11695-011-0496-9.
20. Scopinaro N, Gianetta E, Adami GF, et al. Biliopancreatic diversion for obesity at eighteen years. Surgery. 1996;119(3):261-8. (Pubitemid 26082661)
21. Zhang GY, Wang TT, Cheng ZQ, et al. Resolution of diabetes mellitus by ileal transposition compared with biliopancreatic diversion in a nonobese animal model of type 2 diabetes. Can J Surg. 2011;54(4):243-51. doi:10.1503/cjs. 044209.
22. Borg CM, le Roux CW, Ghatei MA, et al. Biliopancreatic diversion in rats is associated with intestinal hypertrophy and with increased GLP-1, GLP-2 and PYY levels. Obes Surg. 2007;17(9):1193-8. (Pubitemid 351321335)
23. Nannipieri M, Mari A, Anselmino M, et al. The role of β-cell function and insulin sensitivity in the remission of type 2 diabetes after gastric bypass surgery. J Clin Endocrinol Metab. 2011;96(9): E1372-9. doi:10.1210/jc.2011-0446.
24. Koivisto VA. Insulin therapy in type II diabetes. Diabetes Care. 1993;16 Suppl 3:29-39. (Pubitemid 23348319)
25. Weng SG, Zhang B, Feng S, et al. Effects of modified biliopancreatic diversion on glucose tolerance of GK rats. Obes Surg. 2013;23(4): 522-30. doi:10.1007/s11695-012-0830-x.
26. Koshy AA, Bobe AM, Brady MJ. Potential mechanisms by which bariatric surgery improves systemic metabolism. Transl Res. 2013;161(2):63-72. doi:10.1016/j.trsl.2012.09.004.
27. de Luis D, Domingo M, Romero A, et al. Effects of duodenal-jejunal exclusion on beta cell function and hormonal regulation in Goto- Kakizaki rats. Am J Surg. 2012;204(2):242-7. doi:10.1016/j. amjsurg.2011.07.020.
28. Kindel TL, Yoder SM, Seeley RJ, et al. Duodenal-jejunal exclusion improves glucose tolerance in the diabetic, Goto-Kakizaki rat by a GLP-1 receptor- mediated mechanism. J Gastrointest Surg. 2009;13(10):1762-72. doi:10.1007/s11605-009-0912-9.
29. Jiménez A, Casamitjana R, Flores L, et al. Long-term effects of sleeve gastrectomy and Roux-en-Y gastric bypass surgery on type 2 diabetes mellitus in morbidly obese subjects. Ann Surg. 2012;256(6): 1023-9. doi:10.1097/SLA.0b013e318262ee6b.
30. Chronaiou A, Tsoli M, Kehagias I, et al. Lower ghrelin levels and exaggerated postprandial peptide-YY, glucagon-like peptide-1, and insulin responses, after gastric fundus resection, in patients undergoing Roux-en-Y gastric bypass: a randomized clinical trial. Obes Surg. 2012;22(11):1761-70. doi:10.1007/s11695-012-0738-5.
31. Rubino F, Gagner M, Gentileschi P, et al. The early effect of the Roux-en-Y gastric bypass on hormones involved in body weight regulation and glucose metabolism. Ann Surg. 2004;240(2):236-42. (Pubitemid 38963013)
32. Wilson-Pérez HE, Chambers AP, Ryan KK, et al. Vertical sleeve gastrectomy is effective in two genetic mouse models of glucagonlike peptide receptor deficiency. Diabetes. 2013;62(7):2380-5. doi: 10.2337/db12-1498.
33. Nadreau E, Baraboi ED, Samson P, et al. Effects of the biliopancreatic diversion on energy balance in the rat. Int J Obes. 2006;30(3):419-29.
34. Kusminski CM, McTernan PG, Kumar S. Role of resistin in obesity, insulin resistance and type II diabetes. Clin Sci. 2005;109(3):243-56. (Pubitemid 41337128)
35. Pata G, Crea N, Di Betta E, et al. Biliopancreatic diversion with transient gastroplasty and duodenal switch: long-term results of a multicentric study. Surgery. 2013;153(3):413-22. doi:10.1016/j.surg. 2012.06.039.
36. Bradley D, Conte C, Mittendorfer B, et al. Gastric bypass and banding equally improve insulin sensitivity and β cell function. J Clin Invest. 2012;122(12):4667-74. doi:10.1172/JCI64895.
37. Geloneze B, Gelonneze SR, Fiori C, et al. Surgery for nonobese type 2 diabetic patients: an interventional study with duodenal-jejunal exclusion. Obes Surg. 2009;19(8):1077-83. doi:10.1007/s11695-009-9844-4.